Research theme for competitive and other funds (3)：
2022 - 2025 小細胞肺癌オルガノイドを用いた小細胞肺癌発癌過程の理解
2019 - 2023 Establishment of strategy for the treatment of lung cancer harboring rare mutations
2019 - 2022 肺癌オルガノイドライブラリーを用いた新規治療標的の同定
Papers (38)：
Yasuda H, Ichihara E, Sakakibara-Konishi J, Zenke Y, Takeuchi S, Morise M, Hotta K, Sato M, Matsumoto S, Tanimoto A, et al. A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands). 2021. 162. 140-146
Namkoong H, Omae Y, Asakura T, Ishii M, Suzuki S, Morimoto K, Kawai Y, Emoto K, Oler AJ, Szymanski EP, et al. Genome-wide association study in patients with pulmonary Mycobacterium avium complex disease. The European respiratory journal. 2021. 58. 2
Ishioka K, Yasuda H, Hamamoto J, Terai H, Emoto K, Kim TJ, Hirose S, Kamatani T, Mimaki S, Arai D, et al. Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer. Cancer research. 2021. 81. 14. 3916-3929
Ebisudani T, Sugimoto S, Haga K, Mitsuishi A, Takai-Todaka R, Fujii M, Toshimitsu K, Hamamoto J, Sugihara K, Hishida T, et al. Direct derivation of human alveolospheres for SARS-CoV-2 infection modeling and drug screening. Cell reports. 2021. 35. 10. 109218-109218
Terai H, Hamamoto J, Emoto K, Masuda T, Manabe T, Kuronuma S, Kobayashi K, Masuzawa K, Ikemura S, Nakayama S, et al. SHOC2 Is a Critical Modulator of Sensitivity to EGFR-TKIs in Non-Small Cell Lung Cancer Cells. Molecular cancer research : MCR. 2021. 19. 2. 317-328
